InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Roger Jeffs
11 Jun 2026
Director
Sold on a plan
286
$249.12
$71.25K
Mark Coleman
10 Jun 2026
Director
Sold on a plan
643
$249.00
$160.11K
Susan Mahony
10 Jun 2026
Director
Sold on a plan
300
$246.18
$73.85K
Roger Jeffs
10 Jun 2026
Director
Sold on a plan
286
$246.18
$70.41K
Susan Mahony
9 Jun 2026
Director
Sold on a plan
300
$237.21
$71.16K
Mark Coleman
2 Jun 2026
Director
Sold on a plan
5,537
$223.39
$1.24M
Mark Coleman
1 Jun 2026
Director
Sold on a plan
6,000
$230.30
$1.38M
Mark Coleman
29 May 2026
Director
Sold on a plan
6,000
$233.46
$1.40M
Mark Coleman
26 Feb 2026
Director
Sold on a plan
25,000
$161.11
$4.03M
Roger Jeffs
2 Sep 2025
Director
Sold on a plan
13,464
$123.68
$1.67M
Roger Jeffs
29 Aug 2025
Director
Sold on a plan
20,000
$121.27
$2.43M
Roger Jeffs
28 Aug 2025
Director
Sold on a plan
20,000
$121.60
$2.43M
Roger Jeffs
27 Aug 2025
Director
Sold on a plan
20,000
$122.30
$2.45M
Roger Jeffs
26 Aug 2025
Director
Sold on a plan
20,000
$120.03
$2.40M
Roger Jeffs
22 Aug 2025
Director
Sold on a plan
16,694
$120.08
$2.00M
Mark Coleman
28 May 2025
Director
Sold on a plan
3,750
$103.43
$387.86K
Mark Coleman
27 May 2025
Director
Sold on a plan
3,750
$105.47
$395.51K
Mark Coleman
29 May 2024
Director
Sold on a plan
5,248
$75.14
$394.33K
Mark Coleman
28 May 2024
Director
Sold on a plan
5,249
$75.21
$394.77K
Show all 117 transactions →

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 53
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,185,486
History held since 23 Nov 2015